Radiotherapy of stage IVA cervical cancer in the Radiotherapy Department of the Aristide le Dantec Hospital in Dakar

O. Siby, D. Traoré, I. Thiam, M. Mane, O. Sarr, N. Ben Amor, D. Dieng, M. Gaye, A. Dem, M. Dieng
{"title":"Radiotherapy of stage IVA cervical cancer in the Radiotherapy Department of the Aristide le Dantec Hospital in Dakar","authors":"O. Siby, D. Traoré, I. Thiam, M. Mane, O. Sarr, N. Ben Amor, D. Dieng, M. Gaye, A. Dem, M. Dieng","doi":"10.54266/ajo.2.2.72","DOIUrl":null,"url":null,"abstract":"INTRODUCTION: The management of stage IVA cervical cancer is based on radio-chemotherapy followed by utero-vaginal brachytherapy. In this study, we evaluate the results of external radiotherapy on stage IVA cervical cancer. MATERIALS AND METHODS: This was a retrospective, descriptive study. It covered all patients with stage IVA carcinoma of the cervix who received external radiotherapy at the Joliot Curie Institute of the Aristide Le Dantec Hospital from January 2018 to December 2019. RESULTS: We found 164 clinical records of patients, of which 24 patients had stage IVA, (14.3% of all cases). The average age of our patients was 51 years ± 12.13. Seventeen patients (70.9%) had an altered general condition on admission. The predominant histological type was squamous cell carcinoma found in 22 cases (91.6%). Anemia was found in 14 patients, (58.4%). Neo-adjuvant chemotherapy was performed in 21 of our patients (87.5%). Radiotherapy was exclusive in 20 patients (83.3%) and concomitant radio-chemotherapy was performed in 4 patients (16.7%). Normo-fractionated radiotherapy with curative intent was performed in 13 patients (54.2%), and hypo-fractionated radiotherapy with palliative intent was performed in the other 11 patients (45.8%). An objective response was found in 17 cases (70.8%) including 8 in patients who received hypo-fractionated radiotherapy and 9 in patients treated with normo-fractionated radiotherapy at a curative dose. Five patients (20.8%) had acute toxicity and 7 (29.2%) late toxicity. After 3 years of follow-up, 5 patients (29.2%) had loco-regional progression, 9 patients (37.5%) presented loco-regional recurrence and 4 patients (16.7%) presented distant metastases. Overall survival was 26.8% at 3 years. CONCLUSION: Normo-fractionated radiotherapy does not seem superior to palliative hypo-fractionated radiotherapy in terms of clinical response in stage IVA cervical cancer. KEYWORDS: Carcinoma; Uterine cervix; External radiotherapy.","PeriodicalId":52950,"journal":{"name":"South African Journal of Oncology","volume":"1043 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"South African Journal of Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.54266/ajo.2.2.72","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

INTRODUCTION: The management of stage IVA cervical cancer is based on radio-chemotherapy followed by utero-vaginal brachytherapy. In this study, we evaluate the results of external radiotherapy on stage IVA cervical cancer. MATERIALS AND METHODS: This was a retrospective, descriptive study. It covered all patients with stage IVA carcinoma of the cervix who received external radiotherapy at the Joliot Curie Institute of the Aristide Le Dantec Hospital from January 2018 to December 2019. RESULTS: We found 164 clinical records of patients, of which 24 patients had stage IVA, (14.3% of all cases). The average age of our patients was 51 years ± 12.13. Seventeen patients (70.9%) had an altered general condition on admission. The predominant histological type was squamous cell carcinoma found in 22 cases (91.6%). Anemia was found in 14 patients, (58.4%). Neo-adjuvant chemotherapy was performed in 21 of our patients (87.5%). Radiotherapy was exclusive in 20 patients (83.3%) and concomitant radio-chemotherapy was performed in 4 patients (16.7%). Normo-fractionated radiotherapy with curative intent was performed in 13 patients (54.2%), and hypo-fractionated radiotherapy with palliative intent was performed in the other 11 patients (45.8%). An objective response was found in 17 cases (70.8%) including 8 in patients who received hypo-fractionated radiotherapy and 9 in patients treated with normo-fractionated radiotherapy at a curative dose. Five patients (20.8%) had acute toxicity and 7 (29.2%) late toxicity. After 3 years of follow-up, 5 patients (29.2%) had loco-regional progression, 9 patients (37.5%) presented loco-regional recurrence and 4 patients (16.7%) presented distant metastases. Overall survival was 26.8% at 3 years. CONCLUSION: Normo-fractionated radiotherapy does not seem superior to palliative hypo-fractionated radiotherapy in terms of clinical response in stage IVA cervical cancer. KEYWORDS: Carcinoma; Uterine cervix; External radiotherapy.
达喀尔Aristide le Dantec医院放疗部对IVA期宫颈癌进行放疗
简介:IVA期宫颈癌的治疗是基于放化疗和子宫阴道近距离放疗。在本研究中,我们评估体外放疗治疗IVA期宫颈癌的结果。材料和方法:这是一项回顾性、描述性研究。该研究涵盖了2018年1月至2019年12月期间在阿里斯蒂德·勒丹特克医院约里奥·居里研究所接受外部放疗的所有IVA期宫颈癌患者。结果:我们共收集到164例患者的临床记录,其中IVA期24例,占全部病例的14.3%。患者平均年龄51岁±12.13岁。17例(70.9%)患者入院时一般情况发生改变。鳞状细胞癌22例(91.6%)。贫血14例(58.4%)。21例患者(87.5%)接受了新辅助化疗。单纯放疗20例(83.3%),放化疗4例(16.7%)。13例(54.2%)患者行正常分次放疗,其余11例(45.8%)患者行次分次放疗。17例(70.8%)患者客观缓解,其中8例接受次分割放疗,9例接受治疗剂量的正常分割放疗。急性毒性5例(20.8%),晚期毒性7例(29.2%)。随访3年后,局部进展5例(29.2%),局部复发9例(37.5%),远处转移4例(16.7%)。3年总生存率为26.8%。结论:在IVA期宫颈癌的临床疗效方面,正常分次放疗并不优于姑息性次分次放疗。关键词:癌;子宫颈癌;外部放射治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
16
审稿时长
14 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信